Credent Connect N Care IPO

About Credent Connect N Care IPO

The Credent Connect N Care IPO opens on TBA and closes on TBA. The allotment of shares will take place on TBA. The credit of shares to the demat account will take place on TBA. The initiation of refunds will take place on TBA. The listing of shares will take place on TBA.

The offer consists of a fresh issue component. The fresh issue will include 49,68,000 shares aggregating up to ₹[TBA] crores. The total number of shares is 49,68,000 and the aggregate amount is yet to be finalised.

Credent Connect N Care IPO’s price band is set at TBA to TBA per share. The lot size for an application is TBA. The minimum amount of investment required by a retail investor is ₹TBA (TBA shares) (based on upper price). The minimum lot size investment for HNI is TBA.

Credent Connect N Care is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India. They provide comprehensive operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises through end-to-end solutions.

Objectives of Credent Connect N Care IPO

• Investment in their wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement.
  
• Investment in their wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery.
  
• To meet working capital requirements.
  
• Repayment and/or pre-payment, in full or part, of borrowings availed by the Company.
• General corporate purposes.
  

Industry Outlook

As diagnostic laboratories expand their networks and scale up home collection services, logistics providers are expected to deliver seamless end- to- end connectivity ranging from rapid specimen pickups to controlled transport and accurate last- mile delivery. This has positioned logistics capability as a strategic differentiator, compelling players to adopt advanced technologies such as IoT- based tracking, route optimization systems, and real- time temperature monitoring tools. The growing focus on digital integration with laboratory information systems (LIS) and automated reporting mechanisms further intensifies competitive pressure, pushing providers to enhance transparency and minimize sample handling errors.

Simultaneously, the rising share of molecular diagnostics, oncology panels, infectious disease testing, and high- value biospecimens has amplified the need for specialized cold- chain systems and stringent chain-of-custody processes. Logistics partners are increasingly expected to demonstrate validated temperature- controlled infrastructure, trained phlebotomy personnel, WHO- GSDP/GDP compliance, and consistent turnaround times across geographies. Consolidation within the diagnostic industry has concentrated logistics demand among a few high- capacity players, driving competitive intensity and encouraging providers to scale rapidly, expand regional presence, and differentiate on service quality. Moreover, the surge in home testing and decentralized care models has pushed logistics companies to strengthen doorstep networks, manage time- critical deliveries, and ensure operational resilience even in remote or semi- urban markets.

About Credent Connect N Care

Credent Connect N Care is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India. They provide comprehensive operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises through end-to-end solutions.

They commenced their operations in 2015 with a small team of field executives and have since expanded into multiple healthcare service verticals. Their offerings majorly include home sample collection through trained phlebotomists, operations & supply chain services through stationed phlebotomy teams at laboratories and hospitals, deployment of skilled laboratory technicians and paramedical staff for internal operations, and specialized inter-state and intra-state logistics services. Their logistics solutions ensure temperature-controlled and turnaround time (TAT) sensitive movement of blood samples and other healthcare products. In addition to their core healthcare support services, the company provides end-to-end phlebotomy services to diagnostic laboratories, doctors’ clinics, hospitals, and other healthcare institutions by deploying trained and qualified personnel at client locations.

Strengths of Credent Connect N Care

• Comprehensive healthcare ecosystem and logistics platform.
  
• Well established relationships with clients.
  
• Leveraging the experience of their promoters and directors.
  
• Widespread reach in domestic markets.
  

Risks of Credent Connect N Care

• They derive a significant portion of their revenue from operations from their top 10 customers with whom they do not have any firm commitments.
  
• Their business is substantially dependent on the diagnostic and health care companies.
  
• They are exposed to risks relating to loss, damage, contamination or delay in transportation of diagnostic samples.
  
• Their business depends on service-level contracts with clients that are subject to renewal, renegotiation and termination.
  
• Their business is highly dependent on the availability and performance of a large, skilled and geographically dispersed workforce.
  

Anchor Investor Bidding Date: TBA

Registrar: KFin Technologies Limited
Book Running Lead Managers: HEM Securities Limited

Credent Connect N Care Business Model

The company earns its revenue as a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India.

Credent Connect N Care Growth Trajectory

Credent Connect N Care’s Total Income for FY25 was ₹78.235 crores, whereas in FY24 and FY23 it was ₹76.017 crores and ₹59.930 crores, respectively.

The Profit After Tax for FY25 was ₹2.247 crores, whereas in FY24 and FY23 it was ₹2.664 crores and ₹2.696 crores, respectively.

Their EBITDA for FY25 was ₹4.995 crores, whereas in FY24 and FY23 it was ₹4.296 crores and ₹4.009 crores, respectively.

Credent Connect N Care Market Position

As on 30th September 2025, they owned and operated a fleet of 94 commercial vehicles used for sample transportation and related logistic operations. Their operations are headquartered in Ashok Vihar, Delhi, and they operate through 2 warehouses and 4 branch offices across India, including in Mumbai, Pune, Chennai, and Varanasi.

As of 31 March 2025, the company’s Total Income, Profit After Tax, and EBITDA were ₹78.235 crores, ₹2.247 crores, and ₹4.995 crores, respectively.

How to apply for Credent Connect N Care IPO?

• Step 1: Log in to your Kotak Neo Demat account to access IPO investments. Next, select the current IPO section.
• Step 2: Specify IPO details. Enter the number of lots and the price you wish to apply for.
• Step 3: Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.
• Step 4: Mandate Notification. Your UPI app will receive a mandate notification to block funds.
• Step 5: Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.